Kurs Vortag | 214,03 |
Öffnen | 211,56 |
Gebot | 210,10 x 1100 |
Briefkurs | 211,05 x 800 |
Tagesspanne | 209,13 - 214,45 |
52-Wochen-Spanne | 173,45 - 371,16 |
Volumen | |
Durchschn. Volumen | 1.235.018 |
Marktkap. | 33,049B |
Beta (5 J., monatlich) | 1,13 |
Kurs-Gewinn-Verhältnis (roll. Hochrechn.) | 47,32 |
EPS (roll. Hochrechn.) | 4,44 |
Gewinndatum | 07. Feb. 2023 |
Erwartete Dividende & Rendite | N/A (N/A) |
Ex-Dividendendatum | N/A |
1-Jahres-Kursziel | 242,69 |
Before next-generation sequencing (NGS) came along, children and families with rare and undiagnosed genetic diseases often faced years-long diagnostic odysseys.
While visiting her grandparents in Florida, 17-year-old Kate frequented a pond near their house and spent time observing the various species of fish living there.
NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Illumina: At the Phoenix Convention Center in Arizona, representatives from Illumina, a global leader in DNA sequencing and array-based technologies, joined approximately 2000 molecular diagnostic ...